Covid-19. U07.1 COVICOVID-19 , virus identified
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: includes 20 patients with COVID-19 who, in addition to their usual treatments, will take 1 capsule of 200 micrograms of selenium daily for 2 wee
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Detection of COVID-19 based on PCR tests Being 20 to 60 years old Willingness to participate in the study
Exclusion criteria
Exclusion criteria: Breastfeeding and pregnancy Advanced respiratory distress syndrome leading to intubation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of reactive protein-C. Timepoint: The first day and the last day of the intervention. Method of measurement: Blood test.;Serum levels of interleukin-6. Timepoint: The first day and the last day of the intervention. Method of measurement: Using blood sampling, the amount of serum IL6 in pc / dl by the kit.;Blood leukocyte count. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test.;Complete number of lymphocytes. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test.;Complete number of neutrophils. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test.;Lactate Dehydrogenase. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test.;Ferritin. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein hemati
Tehran University of Medical Sciences
Outcome results
None listed